# Precision Medicine in the Treatment of Epilepsy

> **NCT05450822** · — · RECRUITING · sponsor: **Gitte Moos Knudsen** · enrollment: 550 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Levetiracetam Tablets
- **DRUG:** Lamotrigine tablet

## Key facts

- **NCT ID:** NCT05450822
- **Lead sponsor:** Gitte Moos Knudsen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450822, "Precision Medicine in the Treatment of Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05450822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*